Biobot Analytics

From pharmaceutical and life science innovators to healthcare systems and government agencies, Biobot provides population-level intelligence to power faster, more informed decisions.

Biobot Analytics, Inc.'s Privacy Notice describes how it collects, uses, and discloses information through its website, applications, services, tools, and features, or through other interactions.

Biobot Analytics, Inc. operates Biobot.io on its behalf. The Terms of Service cover the website and its content, tools, services, features, and functionality.

Biobot's NIH- and NIDA-funded nationwide wastewater monitoring pilot produces peer-reviewed findings published in Nature Water. Using Biobot's wastewater intelligence platform, the pilot finds that near-real-time substance signals can lead traditional reporting at national scale.

Jun 2026 · Morningstar (PR Newswire)News article

Biobot Analytics is selected by the White House Office of National Drug Control Policy to provide nationwide wastewater intelligence on substance use trends. The company will deliver the intelligence through its proprietary wastewater intelligence platform.

Jan 2026 · PR NewswireNews article

Biobot Analytics is using a venture round led by Valor Equity Partners to expand beyond public health customers into private-sector markets. The company grew out of MIT research and has monitored wastewater for opioids and COVID-19. Its municipal pricing and expanding substance panel are also part of its business model.

Nov 2025 · Cambridge DayNews article

Biobot Analytics announces a new funding round led by Valor Equity Partners. The company says the funding will support its wastewater intelligence platform for healthcare and national security, alongside an expansion of its board of directors.

Jun 2025 · PR NewswireNews article